Related Experiment Video
Updated: Jul 2, 2026

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
Published on: August 18, 2010
Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA
Chiho Komoto1, Tsutomu Nakamura, Motohiro Yamamori
1Department of Hospital Pharmacy, School of Medicine, Kobe University, Kobe 650-0017, Japan.
Abstract:
In previous reports, the effects of 12 Ca2+ antagonists on a multidrug resistant transporter, P-glycoprotein/MDR1, were evaluated in terms of those on MDR1-mediated transport of [3H]digoxin and the sensitivity of vinblastine sulfate or paclitaxel, and they were able to be classified into 4 subgroups based on their actions, as those with transport inhibition and sensitivity recovery, those with or without transport inhibition but marginal sensitivity recovery, and those without both. In this study, our previous findings were confirmed by the resistance against doxorubicin hydrochloride and daunorubicin hydrochloride, and by the recovery of [3H] vinblastine sulfate accumulation. Furthermore, it was found that the effects of 12 Ca2+ antagonists on the sensitivity recovery were also explained by the down-regulation of MDR1 mRNA, suggesting a novel mechanism to reverse the MDR1-mediated multidrug resistance.
Insights
Calcium channel blockers can reverse multidrug resistance by down-regulating P-glycoprotein/MDR1. This study confirms their efficacy and suggests a novel mechanism involving MDR1 mRNA down-regulation for overcoming cancer drug resistance.
Area of Science:
- Pharmacology
- Molecular Biology
- Oncology
Background:
- Multidrug resistance (MDR) is a major challenge in cancer chemotherapy.
- P-glycoprotein (P-gp/MDR1) is a key transporter protein responsible for MDR.
- Calcium (Ca2+) antagonists have shown potential in modulating P-gp activity.
Purpose of the Study:
- To confirm the effects of 12 Ca2+ antagonists on MDR1-mediated drug transport and cellular sensitivity.
- To investigate the underlying molecular mechanisms of Ca2+ antagonist-induced reversal of MDR.
- To explore novel strategies for overcoming MDR in cancer treatment.
Main Methods:
- Evaluation of Ca2+ antagonists' effects on [3H]digoxin transport mediated by P-gp.
- Assessment of cellular sensitivity to vinblastine sulfate, paclitaxel, doxorubicin hydrochloride, and daunorubicin hydrochloride.
- Measurement of [3H]vinblastine sulfate accumulation.
- Analysis of MDR1 mRNA expression levels.
Main Results:
- Ca2+ antagonists were classified into four subgroups based on their effects on P-gp transport and drug sensitivity.
- Previous findings were confirmed using doxorubicin and daunorubicin resistance models.
- Ca2+ antagonists effectively recovered [3H]vinblastine sulfate accumulation in resistant cells.
- Sensitivity recovery was correlated with the down-regulation of MDR1 mRNA expression.
Conclusions:
- Ca2+ antagonists can effectively reverse MDR mediated by P-gp.
- Down-regulation of MDR1 mRNA represents a novel mechanism by which Ca2+ antagonists overcome MDR.
- These findings suggest a potential therapeutic strategy for enhancing chemotherapy efficacy in resistant cancers.
Related Concept Videos
Desensitization and Tachyphylaxis
Several...
Treatment Resistant Cancers
GPCR Desensitization
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
